Extension Med Version MV3

Extension for testing purposes Extension for testing purposes

As of May 2026, Extension Med Version MV3 has users and a 4.00/5 rating from 1 reviews in the Education category.

Usersno change0%
Ratingno change0%
4.00
1 reviews
Reviewsno change0%
1
Version
Extension 62.2
Manifest V3

Permissions & access

Permissions
None declared
Host access
http://www.google.com

Screenshots

Extension Med Version MV3 screenshot 1Extension Med Version MV3 screenshot 2Extension Med Version MV3 screenshot 3Extension Med Version MV3 screenshot 4

About

A free trial extension is a period of time that a user can use a product or service for free, after the initial free trial period has expired. Free trials are typically limited by time, such as a 7-day or 30-day free trial.
Free trial extensions are often offered by companies that want to give users more time to evaluate their product or service before deciding to purchase a subscription. They can also be used to encourage users who have already signed up for a free trial to convert into paying customers.
To request a free trial extension, users typically need to contact the company's customer support team. The company may then ask the user to provide some information about their experience with the product or service, and why they need more time to evaluate it.
If the company approves the request, the user will be given an additional period of time to use the product or service for free. The length of the extension will vary depending on the company's policy.

Technical

Version
Extension 62.2
Manifest
V3
Size
4.23KiB
Min Chrome
88
Languages
1
Featured
No

Metadata

ID
fopmdjlnicpjmhimffnmfbcapgcedmhk
Developer ID
ue0b3da0effa12518714d23b047d3efe1
Developer Email
[email protected]
Created
Mar 27, 2024
Last Updated (Store)
Mar 29, 2024
Last Scraped
May 23, 2026
Website
Support URL
Privacy Policy

Similar extensions

Alternatives to Extension Med Version MV3, ranked by description similarity.

Data sourced from the Chrome Web Store · last verified May 23, 2026.